SCHEMBL31454892

SCHEMBL31454892

CCCc1cc(=O)oc2c(C(=O)N3CCCc4ccccc43)c(O)ccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 12/20 0.56
▸ KDM4E B2RXH2 8/20 0.56
▸ HPGD P15428 8/20 0.56
▸ GAA P10253 6/20 0.56
▸ MAPT P10636 4/20 0.56
▸ NPSR1 Q6W5P4 2/20 0.56
▸ LMNA P02545 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ CYP2C19 P33261 4/20 0.55
▸ GLA P06280 3/20 0.52
▸ HIF1A Q16665 2/20 0.52
▸ CYP3A4 P08684 1/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ POLB P06746 1/20 0.51
▸ ERAP1 Q9NZ08 1/20 0.51
▸ TSHR P16473 2/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31454962 0.97 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454961 0.97 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454869 0.95 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454837 0.93 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454893 0.88 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454894 0.87 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454905 0.87 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454838 0.85 CYP2C19 (0.69) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454840 0.85 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL31454871 0.85 KMT2A (0.52) ALDH1A1KDM4EHPGDGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025042896-A1 DNA TOPOISOMERASE IIβ INHIBITORS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2025-02-27 — — WO disclosed
Send feedback